(Q43719397)

English

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring

scientific article published in January 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

D Layton

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

G L Pearce

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

S A Shakir

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

703-713

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prescription-event and other forms of epidemiological monitoring of side-effects in the UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terminology in prescription-event monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11522122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200124090-00005

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719397&oldid=2206222434"